CEN BIOTECH INC (CENB) financial statements (2021 and earlier)

Company profile

Business Address 300-3295 QUALITY WAY
WINDSOR, ON N8T 3R9
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments20824116
Cash and cash equivalents20824116
Receivables18      
Total current assets:200824116
Noncurrent Assets
Operating lease, right-of-use asset  196199229236250
Property, plant and equipment  139144148153157
Long-term investments and receivables1,2241,2151,1101,1101,1101,08045
Due from related parties1,2241,2151,1101,1101,1101,08045
Intangible assets, net (including goodwill)4,9565,0625,1695,2755,3815,4875,593
Intangible assets, net (excluding goodwill)4,9565,0625,1695,2755,3815,4875,593
Other undisclosed noncurrent assets114      
Total noncurrent assets:6,2946,2786,6136,7286,8696,9566,046
Other undisclosed assets 2803494264244221,415
TOTAL ASSETS:6,3146,5586,9717,1557,2967,3797,477
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,95712,73911,96111,12910,3419,6398,906
Accounts payable191211242186181209207
Accrued liabilities641610579606575526492
Interest and dividends payable1,12511,91711,14010,3379,5858,9048,207
Debt7,70716,40716,00215,58915,30714,98214,480
Due to related parties1,3721,3701,3691,3681,3631,3621,362
Other undisclosed current liabilities3,6704,1024,0423,9403,8583,7402,045
Total current liabilities:14,70634,61833,37432,02630,86829,72326,794
Noncurrent Liabilities
Long-term debt and lease obligation2205666939961,2231,2201,591
Long-term debt, excluding current maturities784275408381,0391,0281,386
Operating lease, liability142139153158184192205
Other undisclosed noncurrent liabilities1,2385815675825561,0302,642
Total noncurrent liabilities:1,4581,2861,4131,7361,7792,2504,234
Total liabilities:16,30635,90434,78733,76132,83231,97331,028
Stockholders' equity
Stockholders' equity attributable to parent(9,992)(29,346)(27,817)(26,606)(25,535)(24,594)(23,550)
Additional paid in capital17,06916,85016,45416,00415,77515,48715,198
Accumulated deficit(27,061)(46,196)(44,270)(42,610)(41,310)(40,081)(38,748)
Total stockholders' equity:(9,992)(29,346)(27,817)(26,606)(25,535)(24,594)(23,550)
TOTAL LIABILITIES AND EQUITY:6,3146,5586,9717,1557,2967,3797,477

Income statement (P&L) ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Operating expenses(354)(968)(690)(531)(661)(517)(997)
Operating loss:(354)(968)(690)(531)(661)(517)(997)
Nonoperating income (expense)19,490(958)(969)(769)(568)(815)(854)
Foreign currency transaction gain (loss), before tax(81)(38)(65)129(27)13(27)
Interest and debt expense(125)(107)(106)(105)(108)(115)(114)
Net income (loss):19,011(2,033)(1,766)(1,406)(1,337)(1,447)(1,965)
Other undisclosed net income attributable to parent125107106105108115114
Net income (loss) available to common stockholders, basic:19,136(1,926)(1,660)(1,300)(1,229)(1,333)(1,851)
Other undisclosed net income available to common stockholders, diluted585      
Net income (loss) available to common stockholders, diluted:19,721(1,926)(1,660)(1,300)(1,229)(1,333)(1,851)

Comprehensive Income ($ in thousands)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):19,011(2,033)(1,766)(1,406)(1,337)(1,447)(1,965)
Comprehensive income (loss), net of tax, attributable to parent:19,011(2,033)(1,766)(1,406)(1,337)(1,447)(1,965)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: